| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| EB | 2,048 | 66.5% | -1.38 | 787 | 96.1% |
| LAL(L) | 623 | 20.2% | -8.28 | 2 | 0.2% |
| CRE(L) | 215 | 7.0% | -7.75 | 1 | 0.1% |
| CentralBrain-unspecified | 183 | 5.9% | -2.66 | 29 | 3.5% |
| BU(L) | 10 | 0.3% | -inf | 0 | 0.0% |
| ROB(L) | 3 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns ER3a_b | % In | CV |
|---|---|---|---|---|---|
| ER3a_b (R) | 3 | GABA | 110 | 11.0% | 0.1 |
| ER3a_c (R) | 2 | GABA | 101 | 10.1% | 0.1 |
| PLP046 (L) | 5 | Glu | 90 | 9.0% | 0.8 |
| ER3a_b (L) | 3 | GABA | 79.7 | 8.0% | 0.1 |
| ER3a_c (L) | 2 | GABA | 76.3 | 7.6% | 0.2 |
| ExR7 (L) | 2 | ACh | 45 | 4.5% | 0.0 |
| ER3a_a (R) | 7 | GABA | 42.7 | 4.3% | 0.7 |
| LHPV6q1 (R) | 1 | unc | 41 | 4.1% | 0.0 |
| ER3a_a (L) | 8 | GABA | 41 | 4.1% | 0.4 |
| ER5 (R) | 10 | GABA | 36.3 | 3.6% | 0.5 |
| ER3a_d (L) | 3 | GABA | 34.7 | 3.5% | 0.9 |
| ExR7 (R) | 2 | ACh | 34 | 3.4% | 0.1 |
| ER5 (L) | 11 | GABA | 29 | 2.9% | 0.4 |
| EL (R) | 9 | OA | 22.3 | 2.2% | 0.6 |
| ER3a_d (R) | 2 | GABA | 20 | 2.0% | 0.4 |
| LAL138 (R) | 1 | GABA | 18 | 1.8% | 0.0 |
| ExR1 (L) | 2 | ACh | 17.3 | 1.7% | 0.2 |
| EL (L) | 8 | OA | 17 | 1.7% | 0.5 |
| ExR1 (R) | 2 | ACh | 16.7 | 1.7% | 0.1 |
| LHPV6q1 (L) | 1 | unc | 15.3 | 1.5% | 0.0 |
| SMP183 (L) | 1 | ACh | 12 | 1.2% | 0.0 |
| LAL055 (L) | 1 | ACh | 11.3 | 1.1% | 0.0 |
| ER3m (R) | 8 | GABA | 11.3 | 1.1% | 0.5 |
| ER3m (L) | 9 | GABA | 8 | 0.8% | 0.6 |
| LAL047 (L) | 1 | GABA | 7 | 0.7% | 0.0 |
| CB4112 (L) | 3 | Glu | 6.3 | 0.6% | 0.5 |
| TuBu02 (L) | 1 | ACh | 5.3 | 0.5% | 0.0 |
| LAL203 (L) | 2 | ACh | 5 | 0.5% | 0.7 |
| LHPV5l1 (L) | 1 | ACh | 4.3 | 0.4% | 0.0 |
| PLP044 (L) | 3 | Glu | 3.7 | 0.4% | 0.3 |
| ExR3 (L) | 1 | 5-HT | 2.3 | 0.2% | 0.0 |
| DGI (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LAL064 (L) | 2 | ACh | 2 | 0.2% | 0.3 |
| ER1_a (R) | 2 | GABA | 2 | 0.2% | 0.0 |
| CB4183 (L) | 1 | ACh | 1.7 | 0.2% | 0.0 |
| ER3d_a (R) | 3 | GABA | 1.7 | 0.2% | 0.3 |
| ER2_c (L) | 2 | GABA | 1.7 | 0.2% | 0.6 |
| DGI (R) | 1 | Glu | 1.3 | 0.1% | 0.0 |
| FB2D (L) | 1 | Glu | 1.3 | 0.1% | 0.0 |
| SMP238 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SIP028 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| ER3w_a (R) | 2 | GABA | 1 | 0.1% | 0.3 |
| ER2_b (L) | 2 | GABA | 1 | 0.1% | 0.3 |
| ER3d_e (L) | 2 | GABA | 1 | 0.1% | 0.3 |
| WEDPN17_c (L) | 2 | ACh | 1 | 0.1% | 0.3 |
| ER3d_c (L) | 2 | GABA | 1 | 0.1% | 0.3 |
| ER3d_e (R) | 2 | GABA | 1 | 0.1% | 0.3 |
| ER2_a (R) | 3 | GABA | 1 | 0.1% | 0.0 |
| PFL1 (R) | 3 | ACh | 1 | 0.1% | 0.0 |
| WEDPN18 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| ER3w_a (L) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| PEG (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| ExR3 (R) | 1 | 5-HT | 0.7 | 0.1% | 0.0 |
| EPG (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| FB6M (L) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| WEDPN7C (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| FB4C (L) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| SMP385 (R) | 1 | unc | 0.7 | 0.1% | 0.0 |
| LAL013 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| CB1504 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| AN09A005 (L) | 1 | unc | 0.3 | 0.0% | 0.0 |
| SMP142 (R) | 1 | unc | 0.3 | 0.0% | 0.0 |
| WED155 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| CB4183 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| ER3d_b (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER2_d (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| LAL100 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER4d (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| PFGs (R) | 1 | unc | 0.3 | 0.0% | 0.0 |
| PFR_a (R) | 1 | unc | 0.3 | 0.0% | 0.0 |
| ER3p_b (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER1_a (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| OLVC5 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| SMP145 (R) | 1 | unc | 0.3 | 0.0% | 0.0 |
| CRE055 (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| FB3C (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| PLP048 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| LAL142 (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| downstream partner | # | NT | conns ER3a_b | % Out | CV |
|---|---|---|---|---|---|
| ER3a_a (L) | 8 | GABA | 121.3 | 11.2% | 0.2 |
| ER3a_a (R) | 7 | GABA | 121 | 11.2% | 0.5 |
| EL (L) | 9 | OA | 108 | 10.0% | 0.3 |
| ER3a_b (R) | 3 | GABA | 106.3 | 9.8% | 0.1 |
| EL (R) | 9 | OA | 90.3 | 8.3% | 0.5 |
| ER3a_b (L) | 3 | GABA | 79.7 | 7.3% | 0.1 |
| ER3a_d (L) | 3 | GABA | 67.7 | 6.2% | 0.4 |
| ER3a_c (R) | 2 | GABA | 62.3 | 5.7% | 0.2 |
| ExR1 (R) | 2 | ACh | 55.3 | 5.1% | 0.2 |
| ExR1 (L) | 2 | ACh | 51 | 4.7% | 0.3 |
| ER3a_d (R) | 2 | GABA | 47.7 | 4.4% | 0.1 |
| ER3a_c (L) | 2 | GABA | 43.3 | 4.0% | 0.1 |
| ER3m (R) | 9 | GABA | 29.3 | 2.7% | 0.7 |
| ER3m (L) | 9 | GABA | 22 | 2.0% | 0.8 |
| ER5 (L) | 11 | GABA | 15 | 1.4% | 0.4 |
| EPG (R) | 12 | ACh | 11.7 | 1.1% | 0.6 |
| EPG (L) | 13 | ACh | 11.7 | 1.1% | 0.7 |
| ER5 (R) | 8 | GABA | 8.7 | 0.8% | 0.7 |
| ER2_a (R) | 5 | GABA | 3.3 | 0.3% | 0.8 |
| ER1_a (R) | 2 | GABA | 3 | 0.3% | 0.3 |
| ER2_a (L) | 5 | GABA | 2.7 | 0.2% | 0.3 |
| ExR3 (R) | 1 | 5-HT | 2.3 | 0.2% | 0.0 |
| ER3d_e (R) | 3 | GABA | 2.3 | 0.2% | 0.8 |
| ExR5 (R) | 1 | Glu | 2 | 0.2% | 0.0 |
| ER4d (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| PEG (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| ER3d_c (L) | 3 | GABA | 1.3 | 0.1% | 0.4 |
| ER3d_a (R) | 3 | GABA | 1.3 | 0.1% | 0.4 |
| ER3d_e (L) | 2 | GABA | 1 | 0.1% | 0.3 |
| ER2_c (L) | 2 | GABA | 1 | 0.1% | 0.3 |
| ER3d_d (R) | 2 | GABA | 1 | 0.1% | 0.3 |
| ER3d_b (R) | 3 | GABA | 1 | 0.1% | 0.0 |
| ER3d_b (L) | 2 | GABA | 0.7 | 0.1% | 0.0 |
| CB4183 (L) | 2 | ACh | 0.7 | 0.1% | 0.0 |
| ER3w_b (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER3p_b (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER3d_a (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER3w_a (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ExR5 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| ER2_c (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER2_d (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER2_d (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ExR3 (L) | 1 | 5-HT | 0.3 | 0.0% | 0.0 |
| PFL1 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| ER3d_d (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER1_b (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ExR7 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
